Molecules in focusIntracellular labile iron
Introduction
The existence of a cellular pool of metabolically available, labile iron (LI), has remained controversial. Firstly, its inherently transient nature, susceptibility to exchange between chemical ligands and to environment-sensitive redox conversions, have made it difficult to chemically quantify or even characterize. Secondly, the actual concept of cellular pools of LI might be considered counterintuitive, as it would entail the heavy cost of coping with continual iron-catalyzed generation of toxic reactive oxygen species (ROS). The development of iron-sensitive fluorescent probes has provided much evidence in favor of intracellular LI pools. Cytosolic LI is still portrayed as a key player in the cell iron-sensing machinery and hub of iron homeostasis (reviewed in Kakhlon & Cabantchik, 2002; Kruszewski, 2003). Yet, there remains considerable uncertainty about the mechanisms by which it affects iron-handling proteins and is in turn influenced by them. The notion of diffusible LI that is randomly bound to cellular ligands of variable affinities does not exclude the possibilities of escorted iron delivery to organelles and ensuing compartmentalization. The purpose of this review is to critically examine these evolving concepts and open questions, and point out new directions for investigating cellular LI.
Section snippets
Probing intracellular labile iron
Probes for LI are comprised of a fluorescent reporter group coupled to a high-affinity iron(II or III) chelator. The fluorophore responds to metal binding by undergoing a change in fluorescence, ideally in a stoichiometric manner. The most commonly used fluorophores include fluorescein and rhodamine derivatives attached to either desferrioxamine, phenanthroline, bipyridyl, ethylene-diamine tetraacetate, ferrichromes (reviewed in Esposito, Epsztejn, Breuer, & Cabantchik, 2002) or pyridinones (
Cellular LI as a chelator-accessible source of reactive oxygen species
The generation of reactive oxygen species (ROS) via the Fenton reaction is virtually unavoidable in cellular systems that contain both redox-active LI and generate reactive oxygen intermediates such as superoxide and/or H2O2. Redox activity requires the cycling of iron between the di- and tri-valent states, which may be expected within cells due to the reducing intracellular environment and activity of ferric reductases. It has been shown that ≥80% of the ∼0.4 μM LI in erythroleukemia K562 cells
Future directions
A major future challenge will be the analysis of LI in crucial compartments using organelle-specific probes. For example, the growing list of neurological diseases recognized as mitochondria-related includes several conditions with suspected disruptions in mitochondrial LI levels.
The model of cellular iron distribution, in which various cellular components receive iron directly from a cytosolic LI pool is likely to undergo revision. Its relevance will depend on the identification of the forms
Acknowledgements
We acknowledge the support of Euroiron1, LSHM-CT-2006-037296, Apotex Inc., Ont. Canada, Association Francaise de Myotonie and the Israeli Science Foundation.
References (20)
- et al.
Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II)
J. Biol. Chem.
(1995) - et al.
A review of fluorescence methods for assessing labile iron in cells and biological fluids
Anal. Biochem.
(2002) - et al.
Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences
Blood
(2006) - et al.
Intracellular labile iron pools as direct targets of iron chelators: A fluorescence study of chelator action in living cells
Blood
(2005) - et al.
The labile iron pool: Characterization, measurement, and participation in cellular processes
Free Radic. Biol. Med.
(2002) Labile iron pool: The main determinant of cellular response to oxidative stress
Mutat. Res.
(2003)- et al.
Mechanism of iron transport to the site of heme synthesis inside yeast mitochondria
J. Biol. Chem.
(1999) - et al.
Iron trafficking in the mitochondrion: Novel pathways revealed by disease
Blood
(2005) - et al.
Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: Examination of the intermediates involved in iron metabolism
Blood
(1996) - et al.
Molecular control of vertebrate iron homeostasis by iron regulatory proteins
Biochim. Biophys. Acta
(2006)